Orin
PGRNYSE·Insurance - Property & Casualty

The Progressive Corporation PGR

Market cap $118.8BP/E 10.2× trailingGross margin 26.9%Reports Wed 14 Oct, before the open
$204.41
+1.27 (+0.63%)live 09:30 ET
52-wk $189.20 – $248.17
Watch
Orin's take
0.62conviction · moderate
Refreshed 18 Aug · take v6. A new filing or a print queues the next refresh.

Progressive's fundamentals remain best-in-class — FY2025 revenue of $87.6B (up 16.3% YoY), diluted EPS of $19.23, and $17.2B in free cash flow support a P/E of 10.37, roughly 22% below the peer median of 13.35 — but the near-term setup has deteriorated since the prior buy call. As of 2026-08-18 the stock at $207.23 trades below both its 50-day ($213.95) and 200-day ($210.25) moving averages with a bearish MACD histogram of -0.81, while insiders have net sold $124.4M over the trailing 24 months including a cluster of executive sales in late July 2026 at $212–220 per share.

The Q2 2026 combined ratio widening to 87.1 signals that further growth may require margin trade-offs, making this a hold until technicals stabilize or the next quarter confirms underwriting discipline.

What could go wrong

  • Combined ratio deterioration. Q2 2026 combined ratio widened to 87.1 per news coverage, suggesting the growth machine may face margin trade-offs as Progressive pushes into bundled auto and home.
  • Insider selling pressure. Net insider dispositions of $124.4M over 24 months, with CEO Griffith selling $7.9M on 2026-07-27 alone, signal limited executive confidence at current levels.
  • Technical breakdown. Stock at $207.23 is below both the 50-day MA of $213.95 and 200-day MA of $210.25 as of 2026-08-18, with RSI at 43.94 and a negative MACD histogram of -0.81.
  • Valuation re-rating stall. Despite a P/E of 10.37 versus peer median 13.35, the discount has not narrowed; if growth decelerates from the 16.3% FY2025 pace, the multiple could compress further.

What would change my mind

Combined ratio improvement. Q3 2026 combined ratio contracts back below 87, confirming underwriting discipline is intact despite growth investmentsbullish
Technical reclaim of 50-day MA. Stock closes above $213.95 (50-day MA) on above-average volume, reversing the current downtrendbullish
Margin compression. Operating margin declines below the FY2025 level of 16.23% for two consecutive quarters, indicating the combined ratio widening is structuralbearish

Where this comes from: FMP FY2025 + derived_metrics · FMP FY2025 · FMP FY2025 · peer_relative. Orin's read on PGR; not advice.

Twelve months actual closes to 2026-09-23 · actual filings

Sept 25Nov 25Jan 26Mar 26May 26Jul 26

50-day average 200-day average · volume below

Largest holders · 13F Q2 2026

Money flow
FilerPositionOf fund
Vanguard Capital Management$8.3B0.2% of fund
Capital Research Global Investors$5.8B0.8% of fund
State Street$5.8B0.2% of fund
Geode Capital Management$3.7B0.2% of fund
Capital World Investors$2.7B0.3% of fund
Bank Of America /De/$2.7B0.2% of fund

133 filers · quarter ended Q2 2026 · positions, not flows

Insiders, last 24 months: 346 Form 4 filings, net −$132.9M. Of the 50 on hand, 0 were open-market purchases and 9 sales— the rest are grants, option exercises and tax withholding.

Ask Orin about PGR

its filings · its transcripts · its numbers

Orin answers questions about PGR from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

Start 3 free days

Where it trades

vs its own 5y · Financial Services
MetricNowOwn medianSector
P/E10.2×17.9×21.6×
EV/EBITDA8.2×13.6×
P/S1.30×1.52×
P/B3.3×4.6×

Its P/E sits below all 5 of the last 5 years (−0.71σ from its own mean).

What the price assumes

-7.3%

free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $17.2B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.

What Wall Street published

42 firms · 2026-09-23
Consensus target

$223

$198$245 · +9% against today's price

How they rate it
  • 16 buy or overweight
  • 22 hold
  • 4 underweight or sell

The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.

Against the companies it is compared to

median P/E 12.2× of 4 peers
CompanyMarket capP/EEV/EBITDAGrossNetROE
PGRThe Progressive Corporation$118B10.2×8.2×26.9%12.8%35%
BACBank of America Corporation$397B12.7×24.1×59.3%17.2%11%
CBChubb Limited$129B11.8×11.9×39.6%18.1%15%
IBKRInteractive Brokers Group, Inc.$158B36.2×14.2×93.3%10.1%21%
TRVThe Travelers Companies, Inc.$75B9.5×7.4×34.7%17.0%26%

The median is of the 4 peers listed above and nothing else — check it against the column. This company trades 16.9% below it. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.

What it has traded at

P/E by fiscal year
FY14 12.4×FY25 11.8×

What its sector has traded at

Financial Services
FY14 29.6×FY26 23.9×

Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.

Discounted cash flow

not recomputed since
ModelFair valueAgainstComputed
Standard DCF$397$204.31 · +95%2026-06-10
Levered DCF$1421$204.31 · +596%2026-06-10

The vendor’s intrinsic-value models. Treat them as a low-growth anchor — for a fast grower the market routinely pays well above a DCF. These were computed against the price in the “against” column, not today’s.

Every estimate on one scale

price $204.41
52-week range$189 – $248
Analyst targets$198 – $245
Standard DCF$397 as of 2026-06-10, when it was $204.31
Levered DCF$1421 as of 2026-06-10, when it was $204.31
At own 5y-median P/E (18×)$358
At 5y P/E range (12–105×)$236 – $2098
At sector P/E (22×)$431

The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.